NeuBase Therapeutics, Inc. Quarterly Operating Lease, Liability in USD from Q2 2021 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
NeuBase Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from Q2 2021 to Q3 2022.
  • NeuBase Therapeutics, Inc. Operating Lease, Liability for the quarter ending September 30, 2022 was $5.89M, a 4.67% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $5.89M -$288K -4.67% Sep 30, 2022 10-K 2022-12-21
Q4 2021 $6.11M Dec 31, 2021 10-Q 2022-02-11
Q3 2021 $6.18M Sep 30, 2021 10-K 2021-12-23
Q2 2021 $6.18M Jun 30, 2021 10-Q 2021-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.